Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) reviews, approves and provides surveillance of all research protocols involving the use of biohazardous materials including recombinant DNA, agents infectious to humans, animals or plants, and other genetically altered organisms and agents.

Committee Members

Craig Frank, IBC Chair Biological Sciences
Evon Hekkala Biological Sciences 
Stephen Holler  Physics
Haruka Minami Psychology
Elizabeth Thrall Chemistry
Qize Wei Biological Sciences
Donald Boyer Non-affiliated member
Joann Casado Non-affiliated member

Pathogenic Agent (human, non-primate, animal, plant) Protocol

Recombinant DNA Protocol 

Additional Resources
National Institutes of Health Institutional Biosafety Committee